stock listing
SomaLogic to List on Nasdaq Following SPAC Merger, Raises $630M
Through the transaction, which values SomaLogic at roughly $1.2 billion, the company received gross cash proceeds of approximately $630 million.
T2 Biosystems Regains Compliance With Nasdaq Listing Requirements
In April the firm received notice that it wasn't in compliance because its common stock didn't maintain a minimum bid price of $1.00 for 30 consecutive business days.
Biocept Files $100M Shelf Registration
The company plans to use the proceeds to support a variety of general expenses, including research and development, administration, sales, marketing, and capital expenditures.
Opko to Offer up to $100M of Common Shares
The company will use net proceeds from the offering for R&D, commercialization of its products, working capital, and other business expenses.
Genetic Technologies Out of Compliance With Nasdaq Listing Rules
The company, which also trades on the Australian Securities Exchange, has 45 days to submit a plan to the Nasdaq as to regaining compliance.